Showing results (21-30 of 241) with videos related to
Sort By:
Pageof 25
British Journal of Hospital Medicine|July 1, 1988
Significance of atrial natriuretic factor in chronic heart failureJ McMurray, A D StruthersThe American Journal of Cardiology|August 1, 1996
Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarctionD Darbar, N C Davidson, N Gillespie, et al.European Heart Journal|February 3, 1998
Can drug effects on mortality in heart failure be predicted by any surrogate measure?K M Yee, A D StruthersCirculation|February 15, 2000
Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failureC A Farquharson, A D StruthersPostgraduate Medical Journal|January 1, 1983
The haemodynamic effects of labetalol under conditions of increased levels of circulating catecholaminesA D Struthers, J L ReidJournal of Cardiovascular Pharmacology|January 1, 1997
The practical assessment of compliance with ACE-inhibitor therapy--a novel approachR J MacFadyen, A D StruthersHeart (British Cardiac Society)|May 17, 2005
Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failureA D Gavin, A D StruthersBritish Journal of Clinical Pharmacology|April 1, 1994
Interactive effects of indomethacin, angiotensin II and frusemide on renal haemodynamics and natriuresis in manJ G Motwani, A D StruthersClinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 1, 1991
Interactions between atrial natriuretic factor and the autonomic nervous systemC C Lang, A D StruthersJournal of Hypertension|November 1, 1991
Angiotensin II augments the stroke volume response to isoprenaline in manP H Seidelin, A D StruthersPageof 25